MAKO Surgical Corp. Schedules 2008 Fourth Quarter and Year-End 2008 Earnings Release and Conference Call for Tuesday, March 10, 2009


FT. LAUDERDALE, Fla., March 3, 2009 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release fourth quarter and year-end 2008 financial results after market close on Tuesday, March 10, 2009. Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference call to review the fourth quarter and year-end 2008 results starting at 4:30 pm EDT on the same day. The call will be concurrently webcast.

To listen to the conference call please dial 888-677-8749 for domestic callers and 913-312-1269 for international callers approximately ten minutes prior to the start time. To access the live audio broadcast or the subsequent archived recording, visit the Investor Relations section of MAKO's website at www.makosurgical.com. Following the call, a webcast replay will be available on MAKO's website, and an audio replay will also be available by calling 888-203-1112 (719-457-0820 for international callers) and entering the passcode 3656491. Both the audio and webcast replays will be available through March 24, 2009.

About MAKO Surgical Corp.

MAKO Surgical Corp. is a medical device company that markets both its robotic-arm interactive orthopedic surgical platform and its proprietary RESTORIS(r) implants for minimally invasive orthopedic knee procedures. The MAKO RIO System (RIO) is a surgeon-interactive tactile platform that incorporates a robotic arm and patient-specific visualization technology and prepares the knee joint for the insertion and alignment of MAKO's resurfacing implants through a minimal incision. The FDA-cleared RIO allows surgeons to provide a precise, consistently reproducible tissue-sparing, bone resurfacing procedure called MAKOplasty(r) to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than 250 licensed or owned patents and patent applications relating to the areas of computer assisted surgery, haptics, robotics and implants. Additional information can be found at www.makosurgical.com.



            

Contact Data